Guihong Wan
Overview
Explore the profile of Guihong Wan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khattab S, Wan G, Xu S, Moseley C, Tran M, Beagles E, et al.
medRxiv
. 2025 Jan;
PMID: 39830283
Background: Dupilumab has been added to National Cancer Comprehensive Network (NCCN) guidelines as a therapeutic strategy for managing certain cutaneous immune-related adverse events (cirAEs) from immune checkpoint inhibitor (ICI) therapy....
2.
de Almeida N, Janosi A, Hong R, Rajeh A, Nogueira F, Szadai L, et al.
Clin Transl Med
. 2024 Jul;
14(7):e1773.
PMID: 39032005
No abstract available.
3.
Wan G, Chen W, Khattab S, Roster K, Nguyen N, Yan B, et al.
Lancet Oncol
. 2024 Jul;
25(8):1053-1069.
PMID: 39025103
Background: Understanding co-occurrence patterns and prognostic implications of immune-related adverse events is crucial for immunotherapy management. However, previous studies have been limited by sample size and generalisability. In this study,...
4.
Wan G, Maliga Z, Yan B, Vallius T, Shi Y, Khattab S, et al.
Brief Bioinform
. 2024 May;
25(3).
PMID: 38701421
Cancer is a complex cellular ecosystem where malignant cells coexist and interact with immune, stromal and other cells within the tumor microenvironment (TME). Recent technological advancements in spatially resolved multiplexed...
5.
Tang K, Rajeh A, Shaw K, Nguyen N, Wan G, Hashemi K, et al.
Br J Dermatol
. 2024 Apr;
191(3):460-462.
PMID: 38676955
No abstract available.
6.
An Y, Liu X, Chen H, Wan G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
. 2024 Feb;
41(1):121-128.
PMID: 38403612
Identification of molecular subtypes of malignant tumors plays a vital role in individualized diagnosis, personalized treatment, and prognosis prediction of cancer patients. The continuous improvement of comprehensive tumor genomics database...
7.
Wan G, Khattab S, Leung B, Zhang S, Nguyen N, Tran M, et al.
Br J Dermatol
. 2024 Feb;
191(1):117-124.
PMID: 38366637
Background: Cutaneous immune-related adverse events (cirAEs) are the most common toxicities to occur in the setting of immune checkpoint inhibitor (ICI) therapy. Identifying patients who are at increased risk of...
8.
Rashdan H, Zhang S, Wan G, Nguyen N, Roster K, Rajeh A, et al.
J Am Acad Dermatol
. 2024 Jan;
90(5):1080-1083.
PMID: 38290617
No abstract available.
9.
Wan G, Maliga Z, Yan B, Vallius T, Shi Y, Khattab S, et al.
bioRxiv
. 2023 Nov;
PMID: 38014067
Background: Cancer is a complex cellular ecosystem where malignant cells coexist and interact with immune, stromal, and other cells within the tumor microenvironment. Recent technological advancements in spatially resolved multiplexed...
10.
Szadai L, Guedes J, Woldmar N, de Almeida N, Janosi A, Rajeh A, et al.
Clin Transl Med
. 2023 Nov;
13(11):e1495.
PMID: 37990633
No abstract available.